Inventor
BALIGA RAMESH
US28 patents
⚠️ This page may combine multiple inventors who share the name “BALIGA RAMESH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IGM BIOSCIENCES INC
16 patentsUS10618978B2Apr 14, 2020
Binding molecules with modified J-chain
IGM BIOSCIENCES INC16 citations94
US10604559B2Mar 31, 2020
Multi-valent hepatitis B virus antigen binding molecules and uses thereof
IGM BIOSCIENCES INC15 citations93
US10400038B2Sep 3, 2019
Modified J-chain
IGM BIOSCIENCES INC21 citations93
US9951134B2Apr 24, 2018
Modified J-chain
IGM BIOSCIENCES INC25 citations93
US11542342B2Jan 3, 2023
Binding molecules with modified J-chain
IGM BIOSCIENCES INC4 citations86
US10954302B2Mar 23, 2021
Anti-PD-L1 antibodies
IGM BIOSCIENCES INC10 citations85
US10975147B2Apr 13, 2021
Modified J-chain
IGM BIOSCIENCES INC8 citations83
US10787520B2Sep 29, 2020
Multimeric bispecific binding molecules specific for CD20 and CD3
IGM BIOSCIENCES INC13 citations83
US10899835B2Jan 26, 2021
IgM Fc and J-chain mutations that affect IgM serum half-life
IGM BIOSCIENCES INC7 citations82
US10689449B2Jun 23, 2020
Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof
IGM BIOSCIENCES INC12 citations80
US11639389B2May 2, 2023
Binding molecules with modified J-chain
IGM BIOSCIENCES INC4 citations75
US11555075B2Jan 17, 2023
Modified J-chain
IGM BIOSCIENCES INC2 citations72
US11401337B2Aug 2, 2022
Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function
IGM BIOSCIENCES INC6 citations72
US11535664B2Dec 27, 2022
Multi-valent hepatitis B virus antigen binding molecules and uses thereof
IGM BIOSCIENCES INC2 citations71
US11578131B2Feb 14, 2023
Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules
IGM BIOSCIENCES INC1 citations65
US12486336B2Dec 2, 2025
Binding molecules with modified J-chain
IGM BIOSCIENCES INC0 citations62
SUTRO BIOPHARMA INC
8 patentsUS9764039B2Sep 19, 2017
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC20 citations91
US10669347B2Jun 2, 2020
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC5 citations82
US9738724B2Aug 22, 2017
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC12 citations82
US9732161B2Aug 15, 2017
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC7 citations82
US11958909B2Apr 16, 2024
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC1 citations71
US10501558B2Dec 10, 2019
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC3 citations71
US12252552B2Mar 18, 2025
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC0 citations61
US11344626B2May 31, 2022
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
SUTRO BIOPHARMA INC0 citations61